Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  HIV Infection

  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 433 articles:
HTML format

Single Articles

    November 2021
  1. LAM JO, Lee C, Gilsanz P, Hou CE, et al
    Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.
    AIDS. 2021 Nov 24. pii: 00002030-900000000-96266.
    PubMed     Abstract available

  2. Statin exposure and risk of cancer in people with and without HIV infection: Erratum.
    AIDS. 2021;35:2411.

  3. PRESSIAT C, Toni TD, Treluyer JM, Yonaba C, et al
    High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy.
    AIDS. 2021;35:2409-2410.

  4. WANG P, McGovern M, Togo Y
    Geographic diversity in authorship of HIV randomized control trial publications.
    AIDS. 2021;35:2407-2409.

  5. BUKKEMS VE, Hidalgo-Tenorio C, Garcia C, van Hulzen AGW, et al
    First pharmacokinetic data of bictegravir in pregnant women living with HIV.
    AIDS. 2021;35:2405-2406.

  6. SNYMAN J, Sanders EJ, Ndung'u T
    COVID-19 in Africa: preexisting immunity and HIV.
    AIDS. 2021;35:2391-2393.

  7. DEAN LT, Chang HY, Goedel WC, Chan PA, et al
    Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USA.
    AIDS. 2021;35:2375-2381.
    PubMed     Abstract available

  8. CARLANDER C, Lagheden C, Eklund C, Nordqvist Kleppe S, et al
    Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    AIDS. 2021;35:2367-2374.
    PubMed     Abstract available

  9. LUCAS GM, Winslow DL
    New onset kidney impairment in a large pre-exposure prophylaxis demonstration project in New South Wales, Australia.
    AIDS. 2021;35:2395-2397.

  10. VANHAMEL J, Laga M
    Measuring progress in the roll-out of pre-exposure prophylaxis: from counting what we know, to knowing what to count.
    AIDS. 2021;35:2389-2390.

  11. TOULOUMI G, Thomadakis C, Pantazis N, Papastamopoulos V, et al
    HIV continuum of care: bridging cross-sectional and longitudinal analyses.
    AIDS. 2021 Nov 11. pii: 00002030-900000000-96268.
    PubMed     Abstract available

  12. DURSTENFELD MS, Sun K, Ma Y, Rodriguez F, et al
    Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96275.
    PubMed     Abstract available

  13. JEUDY J, Patel P, George N, Burrowes S, et al
    Assessment of coronary inflammation in antiretroviral treated people living with HIV infection and active HIV/HCV co-infection.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96274.
    PubMed     Abstract available

  14. CACHAY ER, Hasteh F, Mathews WC
    Using computer-assisted content analysis to advance anal dysplasia natural history research: a validation study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96273.
    PubMed     Abstract available

  15. BIRABAHARAN M, Strunk A, Kaelber DC, Smith DM, et al
    Sex differences in type 2 diabetes mellitus prevalence among persons with HIV: a cross-sectional analysis.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96272.
    PubMed     Abstract available

  16. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
    Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
    PubMed     Abstract available

  17. NEARY J, Langat A, Singa B, Kinuthia J, et al
    Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96270.
    PubMed     Abstract available

  18. ALTHOFF KN, Stewart CN, Humes E, Zhang J, et al
    The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96269.
    PubMed     Abstract available

  19. FOWLER MG, Aizire J, Sikorskii A, Atuhaire P, et al
    Growth deficits in antiretroviral and HIV exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months-of-age.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96277.
    PubMed     Abstract available

  20. MUNOZ-MORENO JA, Carrillo-Molina S, Martinez-Zalacain I, Miranda C, et al
    Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96276.
    PubMed     Abstract available

  21. YIN W, Panakadan S, Shwe YY, Peters K, et al
    Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific.
    AIDS. 2021;35:2229-2232.

  22. MOSES AK, Ghazi T, Naidoo DB, Chuturgoon A, et al
    DNA methylation of MEKKK1: a strategy to reactivate the NF-kappaB pathway and reverse HIV latency.
    AIDS. 2021;35:2221-2224.

  23. FORD N, Crawford KW, Ameyan W
    Rapidly starting antiretroviral therapy to improve outcomes among disadvantaged groups.
    AIDS. 2021;35:2217-2219.

  24. NICHOLS BE, Rosen S
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply.
    AIDS. 2021;35:2235-2236.

  25. CLAASSEN CW, Lindsay B, Riedel DJ, Kafunda I, et al
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs.
    AIDS. 2021;35:2234-2235.

  26. HEIL EL, Pandit NS, Taylor GH
    Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors.
    AIDS. 2021;35:2232-2233.

  27. GENER AR
    Editorial commentary on 'the other side of screening: predictors of treatment and follow-up for anal precancers in a large health system'.
    AIDS. 2021;35:2215-2216.

  28. CACHAY ER, Hadigan C, Mathews WC
    Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail.
    AIDS. 2021;35:2211-2213.

  29. SILVEIRA ELV, Hong JJ, Amancha PK, Rogers KA, et al
    Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy.
    AIDS. 2021;35:2085-2094.
    PubMed     Abstract available

    October 2021
  30. MALMSTROM S, Wagner P, Yilmaz A, Svedhem V, et al
    Failure to restore CD4 count associated with infection-related and non-infection-related cancer.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96281.
    PubMed     Abstract available

  31. EL-NAHAL WG, Shen NM, Keruly JC, Jones JL, et al
    Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96280.
    PubMed     Abstract available

  32. BECASEN JS, Morris JD, Denard CL, Mullins MM, et al
    HIV care outcomes among transgender persons with HIV infection in the united states: a systematic review and meta-analysis, 2006-2021.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96286.
    PubMed     Abstract available

  33. FURSA O, Mocroft A, Lazarus JV, Amele S, et al
    The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96284.
    PubMed     Abstract available

  34. QUINN JR, Goyal A, Ribeiro RM, Massaccesi G, et al
    Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96283.
    PubMed     Abstract available

  35. CEDARBAUM ER, Ma Y, Adimora AA, Bamman M, et al
    Peripheral artery disease and physical function in women with and without HIV.
    AIDS. 2021 Oct 21. pii: 00002030-900000000-96285.
    PubMed     Abstract available

  36. RAMOS-RINCON JM, Menchi-Elanzi M, Pinargote-Celorio H, Mayoral A, et al
    Trends in hospitalizations and deaths in HIV-Infected patients in Spain over two decades.
    AIDS. 2021 Oct 20. pii: 00002030-900000000-96291.
    PubMed     Abstract available

  37. MILLS A, Richmond GJ, Newman C, Osiyemi O, et al
    Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results.
    AIDS. 2021 Oct 13. pii: 00002030-900000000-96294.
    PubMed     Abstract available

  38. SIDDIQUI J, Samuel SK, Hayward B, Wirka KA, et al
    HIV-associated wasting prevalence in the era of modern antiretroviral therapy: a claims database study (2012-2018).
    AIDS. 2021 Oct 12. pii: 00002030-900000000-96296.
    PubMed     Abstract available

  39. EASTMENT MC, Wanje G, Richardson BA, Mwaringa E, et al
    Results of a cluster randomized trial testing the systems analysis and improvement approach to increase HIV testing in family planning clinics in Mombasa, Kenya.
    AIDS. 2021 Oct 8. pii: 00002030-900000000-96295.
    PubMed     Abstract available

  40. OLUNIYI PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al
    HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96299.
    PubMed     Abstract available

  41. RONALD R, Gartland M, Li Z, Zhou N, et al
    Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96298.
    PubMed     Abstract available

  42. YAN H, Peters H, Thorne C
    Neonatal deaths among infants born to women living with HIV in the UK and Ireland 1998-2017.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96297.
    PubMed     Abstract available

  43. BEZEMER D, Blenkinsop A, Hall M, van Sighem A, et al
    In-country acquisition of HIV-1 non-B infection within the Netherlands is frequent, but results in limited onward transmission.
    AIDS. 2021 Oct 5. pii: 00002030-900000000-96312.
    PubMed     Abstract available

  44. SHAIKH K, Bhondoekhan F, Haberlen S, Nakanishi R, et al
    Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.
    AIDS. 2021 Oct 4. pii: 00002030-900000000-96300.
    PubMed     Abstract available

  45. BOZZI G, Meneri M, Peri AM, Taramasso L, et al
    Starting HIV therapy in patients with mitochondrial disease.
    AIDS. 2021;35:2063-2065.

  46. SARKAR S, Haberlen S, Metkus TS, Kingsley L, et al
    HIV serostatus and incident coronary artery stenosis in men with a baseline zero coronary artery calcium.
    AIDS. 2021;35:2061-2063.

  47. TOMIO A, Lupo J, Blanc M, Epaulard O, et al
    Dynamics of anti-HBs antibody decay in vaccinated people with HIV/AIDS.
    AIDS. 2021;35:2059-2061.

  48. HOOVER JR, Frymus DE, Ifafore-Calfee TA
    Recognizing and supporting health workers to advance and sustain HIV gains: lessons from PEPFAR programmes during the COVID-19 response.
    AIDS. 2021;35:2047-2050.

  49. WEINSTEIN ER, Lee JS, Mendez NA, Harkness A, et al
    HIV/AIDS and aging: the new frontier for HIV/AIDS research and care.
    AIDS. 2021;35:2043-2045.

  50. SANDERS EJ, Agutu CA, Graham SM
    Multiple HIV testing strategies are necessary to end AIDS.
    AIDS. 2021;35:2039-2041.

  51. KOENIG LJ, McKnight-Eily LR
    Achieving national HIV prevention goals: the case for addressing depression and other mental health comorbidities.
    AIDS. 2021;35:2035-2037.

  52. NACCARATO M, Kwee F, Zaltzman J, Fong IW, et al
    Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?
    AIDS. 2021;35:2065-2068.

    September 2021
  53. MOLDT B, Gunthard HF, Workowski KA, Little SJ, et al
    Evaluation of HIV-1 reservoir size and broadly neutralizing antibodies (bNAb) susceptibility in acute ART treated individuals.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96307.
    PubMed     Abstract available

  54. KYAW NTT, Kumar AMV, Harries AD, Satyanarayana S, et al
    Synergy between low body mass index and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96306.
    PubMed     Abstract available

  55. BREGER TL, Westreich D, Edmonds A, Edwards JK, et al
    A new smoking cessation "cascade" among women with or at risk for HIV infection.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96305.
    PubMed     Abstract available

  56. MCMAHON JH, Evans VA, Lau JSY, Symons J, et al
    Neurotoxicity with high dose disulfiram and vorinostat used for HIV latency reversal.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96304.
    PubMed     Abstract available

  57. ONYANGO DO, Akelo V, van der Sande MAB, Ridzon R, et al
    Causes of death in HIV-infected and HIV-uninfected children in the child health and mortality prevention surveillance study-Kenya.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96303.
    PubMed     Abstract available

  58. KLINGLER J, Paul N, Laumond G, Schmidt S, et al
    Distinct antibody profiles in HLA-B*57+, HLA-B*57- HIV controllers and chronic progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96309.
    PubMed     Abstract available

  59. VIEIRA VA, Millar J, Adland E, Muenchhoff M, et al
    Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96308.
    PubMed     Abstract available

  60. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy-naive adults with HIV-1 infection.
    AIDS. 2021 Sep 15. pii: 00002030-900000000-96314.
    PubMed     Abstract available

  61. N'TAKPE JB, Gabillard D, Moh R, Gardiennet E, et al
    Elite and viremic HIV-1 controllers in West Africa.
    AIDS. 2021 Sep 14. pii: 00002030-900000000-96315.
    PubMed     Abstract available

  62. QU Y, Weinstein A, Wang Z, Cheng Y, et al
    Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy.
    AIDS. 2021 Sep 13. pii: 00002030-900000000-96316.
    PubMed     Abstract available

  63. STENGER MR, Pathela P, Schumacher C, Burghardt N, et al
    Trends in HIV prevalence by self-report among MSM diagnosed and 1 reported with gonorrhea in six U.S. jurisdictions, 2010-2019.
    AIDS. 2021 Sep 10. pii: 00002030-900000000-96317.
    PubMed     Abstract available

  64. CORLEY MJ, Pang APS, Rasmussen TA, Tolstrup M, et al
    Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96322.
    PubMed     Abstract available

  65. FRANCO S, Horneros J, Soldevila L, Ouchi D, et al
    Single nucleotide polymorphisms in PNPLA3, ADAR-1, and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1/HCV.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96321.
    PubMed     Abstract available

  66. CHOW FC, Callen A, Arechiga V, Saloner D, et al
    Intracranial vascular imaging detects arterial wall abnormalities in persons with treated HIV infection.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96320.
    PubMed     Abstract available

  67. YAGER JL, Brooks KM, Castillo-Mancilla JR, Nemkov C, et al
    Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium, and high adherence to F/TAF vs. F/TDF.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96319.
    PubMed     Abstract available

  68. ABRAHAM AG, Sun J, Sharma A, Yin MT, et al
    The combined effects of age and HIV on the anatomic distribution of cortical and cancellous bone in the femoral neck among men and women.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96318.
    PubMed     Abstract available

  69. CHAN C, Patel P, Johnson K, Vaughan M, et al
    Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia.
    AIDS. 2021;35:1878-1880.

  70. WANG Y, Feng R, Xu J, Shi L, et al
    An updated meta-analysis on the association between HIV infection and COVID-19 mortality.
    AIDS. 2021;35:1875-1878.

  71. VANCE DE, Becker JT
    Using HIV neuropsychological classification methods to predict employment status.
    AIDS. 2021;35:1859-1861.

  72. DOSHI RK, Greenberg AE
    Test, treat, and maintain: rapid initiation of antiretroviral therapy.
    AIDS. 2021;35:1867-1869.

  73. CRAWFORD KW, Nathan M
    Anal neoplasia: prevention or treatment?
    AIDS. 2021;35:1863-1865.

  74. SEELEY J
    Social context and tracing household wealth over time in rural Uganda 1994-2018.
    AIDS. 2021;35:1857-1858.

  75. SANTELLI JS, Chen I, Makumbi F, Wei Y, et al
    Household wealth and HIV incidence over time, rural Uganda, 1994-2018.
    AIDS. 2021;35:1835-1843.
    PubMed     Abstract available

  76. CROWELL TA, Daud II, Maswai J, Owuoth J, et al
    SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020.
    AIDS. 2021 Sep 1. pii: 00002030-900000000-96325.
    PubMed     Abstract available

    August 2021
  77. VISHWANATHAN SA, Zhao C, Luthra R, Khalil GK, et al
    Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from SHIV acquisition by long-acting cabotegravir in macaques.
    AIDS. 2021 Aug 20. pii: 00002030-900000000-96329.
    PubMed     Abstract available

  78. DAMAS J, Ledergerber B, Nadin I, Tarr PE, et al
    Neurocognitive course at two-year follow-up in the neurocognitive assessment in the metabolic and aging cohort (NAMACO) study.
    AIDS. 2021 Aug 19. pii: 00002030-900000000-96330.
    PubMed     Abstract available

  79. MARASINI B, Vyas HK, Lakhashe SK, Hariraju D, et al
    Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
    AIDS. 2021 Aug 16. pii: 00002030-900000000-96332.
    PubMed     Abstract available

  80. LLOYD AR, Savage R, Eaton E
    Opioid use disorder: a neglected human immunodeficiency virus risk in American adolescents.
    AIDS. 2021 Aug 13. pii: 00002030-900000000-96331.
    PubMed     Abstract available

  81. PREMEAUX TA, Moser CB, McKhann A, Hoenigl M, et al
    Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
    AIDS. 2021 Aug 6. pii: 00002030-900000000-96334.
    PubMed     Abstract available

  82. DAH TTE, Yaya I, Mensah E, Coulibaly A, et al
    Rapid antiretroviral therapy initiation and its effect on treatment response in men who have sex with men in West Africa.
    AIDS. 2021 Aug 4. pii: 00002030-900000000-96335.
    PubMed     Abstract available

  83. PASTICCI MB, De Socio GV, Gagliardini R, Merlini E, et al
    Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse.
    AIDS. 2021;35:1708-1710.

  84. MICAN R, Busca Arenzana C, Vasquez J, Daroca G, et al
    Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.
    AIDS. 2021;35:1707-1708.

  85. VAN HOEK AJ, Reitsema M, Xiridou M, van Sighem A, et al
    Offering a choice of daily and event-driven preexposure prophylaxis for men who have sex with men in the Netherlands: a cost-effectiveness analysis.
    AIDS. 2021;35:1677-1682.
    PubMed     Abstract available

  86. BAUGHER AR, Whiteman A, Jeffries WL 4th, Finlayson T, et al
    Black men who have sex with men living in states with HIV criminalization laws report high stigma, 23 U.S. cities, 2017.
    AIDS. 2021;35:1637-1645.
    PubMed     Abstract available

  87. MILLAR JR, Fatti I, Mchunu N, Bengu N, et al
    Second-generation mother-to-child HIV transmission in South Africa is characterized by poor outcomes.
    AIDS. 2021;35:1597-1604.
    PubMed     Abstract available

  88. PRENDERGAST AJ, Szubert AJ, Pimundu G, Berejena C, et al
    The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
    AIDS. 2021;35:1537-1548.
    PubMed     Abstract available

  89. MARCHETTI G, Asmuth D
    Women are from venus: implications for diversified sex-based preexposure prophylaxis approaches.
    AIDS. 2021;35:1691-1693.

    Hepatitis C virus infection and cardiac dysfunction in women.
    AIDS. 2021;35:1689-1690.

    July 2021
  91. MORAKA NO, Garcia-Broncano P, Hu Z, Ajibola G, et al
    Patterns of pre-treatment drug resistance mutations of very early diagnosed and treated infants in botswana.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96339.
    PubMed     Abstract available

  92. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared to HIV-unexposed.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96338.
    PubMed     Abstract available

  93. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Multimorbidity networks associated with frailty among middle aged and older people with HIV.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96337.
    PubMed     Abstract available

  94. TOSKA E, Zhou S, Laurenzi CA, Haghighat R, et al
    Predictors of secondary HIV transmission risk in a cohort of adolescents living with HIV in South Africa.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96336.
    PubMed     Abstract available

  95. WANG M, Boeke CE, Rioja MR, Maparo T, et al
    Feasibility and impact of near-point-of-care integrated TB/HIV testing in Malawi and Zimbabwe.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96342.
    PubMed     Abstract available

  96. DRAK D, Mcmanus H, Vickers T, Heron JE, et al
    Renal impairment in a large-scale HIV pre-exposure prophylaxis implementation cohort.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96341.
    PubMed     Abstract available

    Supplementing glycine and N-acetylcysteine (GlyNAC) rapidly improves health-related quality of life and lowers perception of fatigue in patients with HIV.
    AIDS. 2021;35:1522-1524.

  98. PAPAMANOLI A, Psevdos G
    False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection.
    AIDS. 2021;35:1521-1522.

  99. DOWNING JM, Prince DJ, Sun CJ
    Prevalence of HIV testing among black and white transgender adults, 2016-2019.
    AIDS. 2021;35:1519-1520.

  100. TAN CS, Reeves RK
    HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?
    AIDS. 2021;35:1503-1504.

  101. IPSER JC, Vera JH
    Does duration of HIV infection substitute for age as a risk factor for amyloid deposition?
    AIDS. 2021;35:1501-1502.

    Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis?
    AIDS. 2021;35:1499-1500.

    Pediatric liquid 'single tablet regimens' for HIV-a call to action.
    AIDS. 2021;35:1497-1498.

  104. MCBRIDE B, Shannon K, Strathdee SA, Goldenberg SM, et al
    Structural determinants of HIV/STI prevalence, HIV/STI/sexual and reproductive health access, and condom use among immigrant sex workers globally.
    AIDS. 2021;35:1461-1477.
    PubMed     Abstract available

  105. MARUKUTIRA T, Wood BR
    Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings.
    AIDS. 2021;35:1505-1507.

  106. RAMOS-RINCON JM, Pinargote H, Ramos-Belinchon C, de Mendoza C, et al
    Hepatitis delta in patients hospitalized in Spain (1997-2018).
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96346.
    PubMed     Abstract available

  107. SWINDELLS S, Lutz T, van Zyl L, Porteiro N, et al
    Long-acting cabotegravir + rilpivirine for HIV-1 treatment: ATLAS week 96 results.
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96345.
    PubMed     Abstract available

  108. GODIN A, Eaton JW, Giguere K, Marsh K, et al
    Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96350.
    PubMed     Abstract available

  109. ASIF S, Baxevanidi E, Hill A, Venter F, et al
    The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96351.
    PubMed     Abstract available

  110. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    PubMed     Abstract available

  111. VYAS P, Mathad JS, Leu CS, Naik S, et al
    Impact of HIV status on systemic inflammation during pregnancy.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96348.
    PubMed     Abstract available

  112. AKGUN KM, Krishnan S, Butt AA, Gibert CL, et al
    HIV-infected medical ICU (MICU) survivors without CD4 cell recovery are at increased risk for poor outcomes regardless of viral suppression in a national cohort.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96347.
    PubMed     Abstract available

  113. RONCHETTI AM, Matheron S, Galicier L, Damond F, et al
    Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era.
    AIDS. 2021 Jul 6. pii: 00002030-900000000-96352.
    PubMed     Abstract available

  114. MACPHAIL AI, McLean C, Vujovic O, Hoy JF, et al
    A 44-year-old man with an ulcerating skin rash in the setting of advanced human immunodeficiency virus infection.
    AIDS. 2021;35:1325-1326.

  115. LASRY A, Baker-Goering M
    Cost analyses of HIV treatment should be standardized and report cost drivers.
    AIDS. 2021;35:1311-1312.

  116. DASH PK, Akay-Espinoza C
    FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients.
    AIDS. 2021;35:1309-1310.

  117. DASH PK, Boix V
    Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
    AIDS. 2021;35:1301-1303.

  118. VELDSMAN KA, Laughton B, Janse van Rensburg A, Zuidewind P, et al
    Viral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of age.
    AIDS. 2021;35:1247-1252.
    PubMed     Abstract available

  119. IMBERT E, Hickey MD, Clemenzi-Allen A, Lynch E, et al
    Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
    AIDS. 2021;35:1241-1246.
    PubMed     Abstract available

  120. MOMPER JD, Wang J, Stek A, Shapiro DE, et al
    Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.
    AIDS. 2021;35:1191-1199.
    PubMed     Abstract available

  121. CATTANEO D, Bernacchia D, Beltrami M, Resnati C, et al
    When the absence of an interaction can become clinically relevant.
    AIDS. 2021;35:1327-1328.

  122. WOOD BR, Pozniak AL
    Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!
    AIDS. 2021;35:1305-1307.

  123. KANNO Y, Hau TTT, Kurokawa R, Nomura T, et al
    Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused SIV controllers.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96355.
    PubMed     Abstract available

  124. JIJ OACUTE N SIA, Molina JM, Costagliola D, Supervie V, et al
    Can HIV epidemics among men who have sex with men be eliminated through participation in PrEP rollouts?
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96354.
    PubMed     Abstract available

  125. MWASAKIFWA GE, Amin J, Kelleher A, Boyd MA, et al
    Inflammatory biomarker and soft tissue changes among patients commencing second-line ART after first-line virological failure.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96353.
    PubMed     Abstract available

    June 2021
  126. SANTOS JCV, Orsi JSR, Ribeiro VS, Tuon FF, et al
    The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96357.

  127. GILMORE JC, Zhang G, Cameron DW, Serghides L, et al
    Impact of in utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96356.
    PubMed     Abstract available

  128. LESKO CR, Hutton HE, Fojo AT, Shen NM, et al
    Depression and HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96361.
    PubMed     Abstract available

  129. LIU G, Mugo NR, Brown ER, Mgodi NM, et al
    Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96360.
    PubMed     Abstract available

  130. BURKE RM, Henrion MYR, Mallewa J, Masamba L, et al
    Incidence of HIV-positive admission and inpatient mortality in Malawi [2012-2019]: a population cohort study.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96359.
    PubMed     Abstract available

  131. CREPAZ N, Song R, Lyss S, Hall HI, et al
    Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014-2018.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96358.
    PubMed     Abstract available

  132. MHLEKUDE B, Lenman A, Sidoyi P, Joseph J, et al
    The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission.
    AIDS. 2021 Jun 21. pii: 00002030-900000000-96362.
    PubMed     Abstract available

  133. KREBS E, Enns E, Zang X, Mah CS, et al
    Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US cities.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96365.
    PubMed     Abstract available

  134. SUZUKI K, Levert A, Yeung J, Starr M, et al
    HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96364.
    PubMed     Abstract available

  135. ROWLINSON E, Mawandia S, Ledikwe J, Bakae O, et al
    HIV testing criteria to reduce testing volume and increase positivity in Botswana.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96367.
    PubMed     Abstract available

  136. ZIMBA S, Nutakki A, Chishimba L, Chomba M, et al
    Risk factors and outcomes of HIV-associated stroke in Zambia.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96366.
    PubMed     Abstract available

  137. CHAN TY, De Zan V, Gregg A, Alagaratnam J, et al
    Cerebrospinal fluid HIV RNA escape symptomatology.
    AIDS. 2021 Jun 15. pii: 00002030-900000000-96370.
    PubMed     Abstract available

  138. GRANGER LA, Huettner I, Debeljak F, Kaleebu P, et al
    Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection SPARTAC cohort.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96373.
    PubMed     Abstract available

  139. MORROW M, Mawhinney S, Coyle RP, Coleman SS, et al
    Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96372.
    PubMed     Abstract available

  140. FAJNZYLBER J, Sharaf R, Hutchinson JN, Aga E, et al
    Frequency of Post Treatment Control Varies by ART Restart and Viral Load Criteria.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96371.
    PubMed     Abstract available

  141. SHEN Y, Shiau S, Strehlau R, Burke M, et al
    Persistently lower bone mass and bone turnover among south african children living with well-controlled HIV.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96369.
    PubMed     Abstract available

  142. GENBERG BL, Wilson-Barthes MG, Omodi V, Hogan JW, et al
    Microfinance, retention in care, and mortality among patients enrolled in HIV 2 Care in East Africa.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96376.
    PubMed     Abstract available

  143. CLAYTOR JD, Viramontes O, Conner S, Wen KW, et al
    TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96375.
    PubMed     Abstract available

  144. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    PubMed     Abstract available

  145. NWOGU JN, Gandhi M, Owen A, Khoo S, et al
    Associations between efavirenz concentrations, pharmacogenetics, and neurocognitive performance in people living with HIV in Nigeria.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96381.
    PubMed     Abstract available

  146. ROLLE CP, Berhe M, Singh T, Ortiz R, et al
    Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96380.
    PubMed     Abstract available

  147. HEATH K, Levi J, Hill A
    Reaching UNAIDS 95-95-95 targets worldwide: predicted benefits and treatment costs with generic manufacture.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96379.
    PubMed     Abstract available

  148. ROBERTSON J, Eden A, Nystrom K, Hagberg L, et al
    Increased immune activation and signs of neuronal injury in HIV-negative people on pre-exposure prophylaxis (PrEP).
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96378.
    PubMed     Abstract available

  149. KOEHN K, Cassidy-Matthews C, Pearce M, Aspin C, et al
    Rates of new HIV diagnoses among Indigenous peoples in Canada, Australia, New Zealand, and the United States: 2009-2017.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96377.
    PubMed     Abstract available

  150. GABRIEL EM, Salinas TRW, Gosselin A, Larouche-Anctil E, et al
    Overt IL-32 Isoform Expression at Intestinal Level during HIV-1 Infection is Negatively Regulated by IL-17A.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96384.
    PubMed     Abstract available

  151. HERRERA C, Harman S, Aldon Y, Rogers P, et al
    The entry inhibitor DS003 (BMS-599793), a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96382.
    PubMed     Abstract available

  152. ANDREIA A, Cappello C, Stirrup O
    High-risk hpv, precancerous lesions and cancer in anal condylomas: systematic review and meta-analysis.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96383.
    PubMed     Abstract available

  153. GUARDIGNI V, Toschi A, Badia L, Del Turco ER, et al
    Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96387.
    PubMed     Abstract available

  154. JIN F, Amin J, Guy R, Vaccher S, et al
    Adherence to daily HIV Pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96386.
    PubMed     Abstract available

  155. MAKADZANGE TA, Hlupeni A, Machekano R, Boyd K, et al
    Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96385.
    PubMed     Abstract available

  156. PETERSON M, Sarita Shah N, Smith-Jeffcoat SE, Nichols C, et al
    Global progress and gaps in tuberculosis screening and treatment among people with HIV: experience from 32 countries.
    AIDS. 2021;35:1154-1156.

  157. NIGHTINGALE S, Dreyer AJ, Gisslen M, Winston A, et al
    Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
    AIDS. 2021;35:1152-1153.

  158. WIERSINGA WJ, van der Valk M
    Severe coronavirus disease 2019 in a patient with HIV-2 infection.
    AIDS. 2021;35:1151-1152.

  159. VIEIRA VA, Fairlie L
    Effects of preconception antiretroviral therapy in placenta development and pregnancy outcomes.
    AIDS. 2021;35:1139-1141.

  160. ROMANELLI A, Moore D
    The importance of wearables: sleep assessment devices for people with HIV.
    AIDS. 2021;35:1137-1138.

    Disregarding drug resistance mutations without peril.
    AIDS. 2021;35:1135-1136.

  162. BOYD AT, Ogbanufe O, Onyenuobi C, Mgbakor I, et al
    Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020.
    AIDS. 2021;35:1127-1134.
    PubMed     Abstract available

  163. BOURDON M, Garnier A, Maignien C, Marcellin L, et al
    Assisted reproductive technology outcomes in women with a chronic viral disease.
    AIDS. 2021;35:1073-1081.
    PubMed     Abstract available

  164. ACKERMAN P, Thompson M, Molina JM, Aberg J, et al
    Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1.
    AIDS. 2021;35:1061-1072.
    PubMed     Abstract available

  165. PENG AT, Huang SH, Sun HY, Huang YC, et al
    Use of dietary supplements containing polyvalent cations and antacids among people living with HIV and its impact on viral suppression.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96390.
    PubMed     Abstract available

  166. HAMEIRI-BOWEN D, Sovershaeva E, Flaegstad T, Gutteberg TJ, et al
    Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96389.
    PubMed     Abstract available

  167. APARICIO JM, Xu Y, Li Y, Colantuoni C, et al
    Plasma microRNAs are associated with domain-specific cognitive function in people with HIV.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96388.
    PubMed     Abstract available

    May 2021
  168. BADE AN, Gendelman HE, McMillan J, Liu Y, et al
    Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue.
    AIDS. 2021 May 27. pii: 00002030-900000000-96396.
    PubMed     Abstract available

  169. STIER EA, Engels E, Horner MJ, Robinson B, et al
    Cervical cancer incidence stratified by age in women living with HIV compared with the general population in the United States, 2002-2016.
    AIDS. 2021 May 27. pii: 00002030-900000000-96395.
    PubMed     Abstract available

  170. PAPASAVVAS E, Azzoni L, Ross BN, Fair M, et al
    Comparable HIV suppression by pegylated-IFN-alpha2a or pegylated-IFN-alpha2b during a 4-week analytical treatment interruption.
    AIDS. 2021 May 27. pii: 00002030-900000000-96394.
    PubMed     Abstract available

    Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand.
    AIDS. 2021 May 27. pii: 00002030-900000000-96393.
    PubMed     Abstract available

  172. CORMA-GOMEZ A, Macias J, Tellez F, Morano L, et al
    Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
    AIDS. 2021 May 27. pii: 00002030-900000000-96392.
    PubMed     Abstract available

  173. YU X, Westra JR, Giordano TP, Berenson AB, et al
    Assessing comorbidities and survival in HIV-infected and uninfected matched Medicare enrollees.
    AIDS. 2021 May 27. pii: 00002030-900000000-96391.
    PubMed     Abstract available

  174. TEMU TM, Wagoner J, Masyuko S, O'Connor A, et al
    Central obesity is a contributor to systemic inflammation and monocyte activation in virally suppressed adults with chronic HIV in Kenya.
    AIDS. 2021 May 24. pii: 00002030-900000000-96400.
    PubMed     Abstract available

  175. KOWALSKA JD, Pelchen-Matthews A, Ryom L, Losso MH, et al
    Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015.
    AIDS. 2021 May 24. pii: 00002030-900000000-96399.
    PubMed     Abstract available

  176. NOVITSKY V, Steingrimsson J, Howison M, Dunn C, et al
    Longitudinal typing of molecular HIV clusters in a statewide epidemic.
    AIDS. 2021 May 24. pii: 00002030-900000000-96398.
    PubMed     Abstract available

  177. TU W, Johnson E, Fujiwara E, Gill MJ, et al
    Predictive variables for peripheral neuropathy in treated HIV-1 infection revealed by machine learning.
    AIDS. 2021 May 24. pii: 00002030-900000000-96397.
    PubMed     Abstract available

  178. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Mutunga L, et al
    High conversion of tuberculin skin tests during the first year of ART among South African adults in primary care.
    AIDS. 2021 May 19. pii: 00002030-900000000-96402.
    PubMed     Abstract available

  179. SILVERA R, Martinson T, Gaisa MM, Liu Y, et al
    The other side of screening: predictors of treatment and follow-up for anal precancers in a large health system.
    AIDS. 2021 May 19. pii: 00002030-900000000-96401.
    PubMed     Abstract available

  180. VAN DEN ELSHOUT MAM, Hoornenborg E, Achterbergh RCA, Coyer L, et al
    Improving adherence to daily PrEP among MSM in Amsterdam by providing feedback via a mobile application.
    AIDS. 2021 May 17. pii: 00002030-900000000-96403.
    PubMed     Abstract available

  181. PASTORI C, Galli L, Siracusano G, Spagnuolo V, et al
    Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1 infected subjects.
    AIDS. 2021 May 14. pii: 00002030-900000000-96404.
    PubMed     Abstract available

  182. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    PubMed     Abstract available

  183. DHAIRYAWAN R, Okhai H, Hill T, Sabin CA, et al
    Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity.
    AIDS. 2021 May 10. pii: 00002030-900000000-96411.
    PubMed     Abstract available

  184. HAMADY A, Cooke GS, Garvey LJ
    Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.
    AIDS. 2021 May 10. pii: 00002030-900000000-96410.
    PubMed     Abstract available

  185. CHADWICK D, Forbes G, Lawrence C, Lorrimer S, et al
    Using an electronic health record alert to prompt blood-borne virus testing in primary care.
    AIDS. 2021 May 10. pii: 00002030-900000000-96408.
    PubMed     Abstract available

  186. PATHELA P, Jamison K, Braunstein SL, Borges CM, et al
    Initiating antiretroviral treatment for newly diagnosed HIV patients in sexual health clinics greatly improves timeliness of viral suppression.
    AIDS. 2021 May 10. pii: 00002030-900000000-96407.
    PubMed     Abstract available

  187. KEENE CM, Griesel R, Zhao Y, Gcwabe Z, et al
    Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line in adults failing a tenofovir-based first-line regimen: a prospective cohort study.
    AIDS. 2021 May 10. pii: 00002030-900000000-96409.
    PubMed     Abstract available

  188. MACHINGURA F, Chabata S, Busza J, Jamali G, et al
    Potential reduction in female sex workers' risk of contracting HIV during Covid-19.
    AIDS. 2021 May 7. pii: 00002030-900000000-96406.
    PubMed     Abstract available

  189. ROYSTON L, Isnard S, Calmy A, Routy JP, et al
    Kaposi sarcoma in ART-treated people living with HIV: A wake-up call for research on HHV-8.
    AIDS. 2021 May 5. pii: 00002030-900000000-96414.

  190. GARBER DA, Guenthner P, Mitchell J, Ellis S, et al
    Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.
    AIDS. 2021 May 5. pii: 00002030-900000000-96412.
    PubMed     Abstract available

  191. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    PubMed     Abstract available

  192. KUMWENDA T, Buleya S, Matanje B, Heller T, et al
    Cardiovascular risk assessment for primary prevention in Malawian HIV patients on ART: are measurements of glycated hemoglobin and lipids worth the effort?
    AIDS. 2021;35:997-999.

  193. LAPARRA A, Lerolle N, Gerin M, Cheret A, et al
    Tumor necrosis factor-alpha inhibitors for extended or severe neurological immune reconstitution inflammatory syndrome in HIV-infected patients.
    AIDS. 2021;35:995-997.

  194. TARAMASSO L, Stapleton JT, Siedner MJ
    Weight gain and aging in people with HIV.
    AIDS. 2021;35:987-989.

    Maternal HIV infection and antiretroviral exposure during pregnancy in fetuses and newborns: when solving one problem opens up a Pandora's box of new conundrums.
    AIDS. 2021;35:985-986.

  196. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed.
    AIDS. 2021;35:921-931.
    PubMed     Abstract available

  197. SHADE SB, Osmand T, Kwarisiima D, Brown LB, et al
    Costs of integrating hypertension care into HIV care in rural East African clinics.
    AIDS. 2021;35:911-919.
    PubMed     Abstract available

  198. LEAL VNC, Reis EC, Fernandes FP, Soares JLDS, et al
    Common pathogen-associated molecular patterns induce the hyper-activation of NLRP3 inflammasome in circulating B lymphocytes of HIV-infected individuals.
    AIDS. 2021;35:899-910.
    PubMed     Abstract available

  199. CHAN MS, Morales A, Zlotorzynska M, Sullivan P, et al
    Estimating the influence of Twitter on pre-exposure prophylaxis use and HIV testing as a function of rates of men who have sex with men in the United States.
    AIDS. 2021;35.
    PubMed     Abstract available

  200. LI Z, Qiao S, Jiang Y, Li X, et al
    Building a social media-based HIV risk behavior index to inform the prediction of HIV new diagnosis: a feasibility study.
    AIDS. 2021;35.
    PubMed     Abstract available

  201. ZHENG C, Wang W, Young SD
    Identifying HIV-related digital social influencers using an iterative deep learning approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  202. WANG B, Liu F, Deveaux L, Ash A, et al
    Adolescent HIV-related behavioural prediction using machine learning: a foundation for precision HIV prevention.
    AIDS. 2021;35.
    PubMed     Abstract available

  203. ZENG C, Zhang J, Sun X, Li Z, et al
    County-level predictors of retention in care status among people living with HIV in South Carolina from 2010 to 2016: a data-driven approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  204. YANG X, Zhang J, Chen S, Weissman S, et al
    Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  205. CHEN S, Owolabi Y, Dulin M, Robinson P, et al
    Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA.
    AIDS. 2021;35.
    PubMed     Abstract available

  206. OLATOSI B, Sun X, Chen S, Zhang J, et al
    Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina.
    AIDS. 2021;35.
    PubMed     Abstract available

  207. WEISSMAN S, Yang X, Zhang J, Chen S, et al
    Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis.
    AIDS. 2021;35.
    PubMed     Abstract available

  208. OLATOSI B, Vermund SH, Li X
    Power of Big Data in ending HIV.
    AIDS. 2021;35.
    PubMed     Abstract available

  209. HASSOLD N, Baltes V, Martin A, Mechai F, et al
    Hemorrhagic cystitis from BK virus in a patient with AIDS.
    AIDS. 2021;35:999-1001.

    April 2021
  210. BROUILLETTE MJ, Koski L, Forcellino L, Gasparri J, et al
    Predicting occupational outcomes from neuropsychological test performance in older people with HIV.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96417.
    PubMed     Abstract available

  211. HUNG R, Patel N, Fox J, Cosgrove C, et al
    Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96416.
    PubMed     Abstract available

  212. MCCANN K, Shah S, Hindley L, Hill A, et al
    Implications of weight gain with newer antiretrovirals: 10-year predictions of cardiovascular disease and diabetes.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96415.
    PubMed     Abstract available

  213. DIRAJLAL-FARGO S, Sattar A, Yu J, Albar Z, et al
    Lipidome Association with Vascular Disease and Inflammation in HIV+ Ugandan Children.
    AIDS. 2021 Apr 19. pii: 00002030-900000000-96419.
    PubMed     Abstract available

  214. SLAMA L, Barrett BW, Abraham AG, Palella FJ Jr, et al
    Risk for incident diabetes is greater in pre-diabetic men with HIV than without HIV.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96422.
    PubMed     Abstract available

  215. SHITOLE SG, Lazar JM, Hanna DB, Kim RS, et al
    HIV, HCV and risk of new-onset left ventricular dysfunction: the women's interagency HIV study.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96421.
    PubMed     Abstract available

  216. LAU JSY, McMahon JH, Gubser C, Solomon A, et al
    The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96420.
    PubMed     Abstract available

  217. KALMIN MM, Westreich D, Drummond BM, Sun J, et al
    Incident obstructive lung disease and mortality among HIV-positive and negative persons with a history of injecting drugs.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96436.
    PubMed     Abstract available

  218. SANDAMANN L, Stoll M, Behrens GMN
    Hypophosphatemia in people living with HIV: No benefit when switching from TDF to TAF.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96435.
    PubMed     Abstract available

  219. SEKABIRA R, Mcgowan I, Yuhas K, Brand RM, et al
    Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96434.
    PubMed     Abstract available

  220. JENNESS SM, Knowlton G, Smith DK, Marcus JL, et al
    A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96433.
    PubMed     Abstract available

  221. GIANOTTI N, Galli L, Poli A, Torre LD, et al
    Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96432.
    PubMed     Abstract available

  222. SADOUNI M, Durand M, Boldeanu I, Danielli C, et al
    Association of Epicardial Fat with Non-Calcified Coronary Plaque Volume and With Low Attenuation Plaque in People Living with HIV.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96431.
    PubMed     Abstract available

  223. KARIUKI SM, Selhorst P, Abrahams MR, Rebe K, et al
    Neutralization sensitivity of genital tract HIV-1: shift in selective milieu shapes the population available to transmit.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96430.
    PubMed     Abstract available

  224. BASTARD JP, Pelloux V, Alili R, Fellahi S, et al
    Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir/maraviroc.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96429.
    PubMed     Abstract available

  225. APORNPONG T, Grinsztejn B, Hughes M, Ritz J, et al
    Antiretroviral Hair Levels, Self-Reported Adherence and Virologic Failure in Second-Line Regimen Patients in Resource-Limited Settings.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96428.
    PubMed     Abstract available

  226. MACBRAYNE CE, Rutstein RM, Wiznia AA, Graham B, et al
    Etravirine in treatment-experienced HIV-1 infected children 1-<6 years of age.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96427.
    PubMed     Abstract available

  227. FEINSTEIN MJ, Haberlen SA, Ashikaga H, Palella FJ, et al
    Ventricular ectopy and arrhythmia by HIV serostatus, viremia, and CD4+ cell count.
    AIDS. 2021;35:846-849.

  228. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.

  229. DRAK D, Dahwa R, Reakes E, Heron JE, et al
    Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy.
    AIDS. 2021;35:843-845.

  230. IKUMI NM, Malaba TR, Pillay K, Cohen MC, et al
    Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women.
    AIDS. 2021;35:717-726.
    PubMed     Abstract available

  231. STECHER C, Linnemayr S
    Promoting antiretroviral therapy adherence habits: a synthesis of economic and psychological theories of habit formation.
    AIDS. 2021;35:711-716.

    March 2021
  232. FRANCO S, Buccione D, Tural C, Martinez MA, et al
    Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96441.
    PubMed     Abstract available

  233. BERGLOV A, Moseholm E, Katzenstein TL, Johansen IS, et al
    Prevalence and association with birth outcomes of low Vitamin D levels among pregnant women living with HIV.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96440.
    PubMed     Abstract available

  234. MORGELLO S, Cortes EP, Gensler G, Meloni G, et al
    HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96439.
    PubMed     Abstract available

  235. RAVA M, Bisbal O, Dominguez-Dominguez L, Aleman MR, et al
    Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96438.
    PubMed     Abstract available

  236. MAXI JK, Foret BL, Amedee A, Mcdaniel LS, et al
    ART administration reduces neuroinflammation without restoring BDNF signaling in alcohol-administered SIV-infected macaques.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96437.
    PubMed     Abstract available

  237. COLLINS LF, Shantha JG, Nesper PL, Sheth AN, et al
    Assessment of retinal microvascular health by optical coherence tomography angiography among persons with HIV.
    AIDS. 2021 Mar 23. pii: 00002030-900000000-96442.
    PubMed     Abstract available

  238. GROVE M, Brown LL, Knudsen HK, Martin EG, et al
    Employing telehealth within HIV care: Advantages, challenges, and recommendations.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96447.

  239. LIN SH, Wang Y, Hartley SW, Karyadi DM, et al
    In utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96446.
    PubMed     Abstract available

  240. SMITH T, Masciotra S, Luo W, Sullivan V, et al
    Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96445.
    PubMed     Abstract available

  241. LAKE JE, LA K, Erlandson KM, Adrian S, et al
    Tesamorelin Improves Fat Quality Independent of Changes in Fat Quantity.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96444.
    PubMed     Abstract available

  242. TRAN H, Saleem K, Lim M, Chow EPF, et al
    Global estimates for the lifetime cost of managing HIV: a systematic review.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96443.
    PubMed     Abstract available

  243. JAO J, Jacobson DL, Russell JS, Wang J, et al
    Perinatally acquired HIV infection is associated with abnormal blood mitochondrial function during childhood/adolescence.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96451.
    PubMed     Abstract available

  244. CUTRELL AG, Schapiro JM, Perno CF, Kuritzkes DR, et al
    Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis across three phase 3 studies.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96450.
    PubMed     Abstract available

  245. CLUVER L, Shenderovich Y, Toska E, Rudgard WE, et al
    Clinic and care: associations with adolescent ART adherence in a prospective cohort in South Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96449.
    PubMed     Abstract available

  246. NGUYEN PT, Gilmour S, Le PM, Onishi K, et al
    Progress toward HIV elimination goals: trends in and projections of Annual HIV testing and condom use in Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96448.
    PubMed     Abstract available

  247. BUTEL-SIMOES G, Woolley I, McMahon J, Yeo A, et al
    IgG4-related disease masquerading as a fungating groin lesion in a patient with HIV and incomplete immune reconstitution.
    AIDS. 2021;35:706-707.

  248. HIREMATH PM, Suri D, Arora K, Shandilya J, et al
    Human leukocyte antigen B27 and B57 alleles in HIV-infected long-term nonprogressor children.
    AIDS. 2021;35:703-705.

  249. AGWU AL, Flynn PM
    Increasing the urgency to identify adolescents and young adults with HIV infection...do or die.
    AIDS. 2021;35:693-695.

  250. LURAIN K, Mbulaiteye SM
    Does HIV undermine breast cancer outcomes in women?
    AIDS. 2021;35:689-690.

  251. KOJIMA N, Klausner JD
    Preexposure prophylaxis is effective on a national level, but is it enough.
    AIDS. 2021;35:691-692.

  252. METSU D, Aquilina C, Delobel P, Gandia P, et al
    Maraviroc exposure is influenced by exogenous thyrotoxicosis.
    AIDS. 2021;35:701-703.

  253. PETT SL, Spyer M, Haddow LJ, Nhema R, et al
    Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
    AIDS. 2021;35:585-594.
    PubMed     Abstract available

  254. DALEL J, Ung SK, Hayes P, Black SL, et al
    HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96472.
    PubMed     Abstract available

  255. THIMM MA, Eke AC
    Tenofovir, pregnancy and renal function changes in pregnant women living with HIV.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96471.
    PubMed     Abstract available

  256. DEJONG C, Spinelli MA, Okochi H, Gandhi M, et al
    Tenofovir-based PrEP for COVID-19: an untapped opportunity?
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96470.

  257. BULSTRA CA, Reddy CL, Atun R, Barnighausen T, et al
    Impact of the COVID-19-related global recession on the financing of the global HIV response.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96469.

  258. FRENCH AL, Grennan D, Daubert E, Seaberg EC, et al
    Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/HCV co-infected women.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96468.
    PubMed     Abstract available

  259. NICKOLAS TL, Barasch J, Mugwanya KK, Branch AD, et al
    Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96467.
    PubMed     Abstract available

  260. MERCURIO V, Fitzgerald W, Vanpouille C, Molodtsov I, et al
    Mechanisms of residual immune activation in HIV-1 infected human lymphoid tissue ex vivo.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96466.
    PubMed     Abstract available

  261. TAKAHASHI N, Ardeshir A, Holder GE, Cai Y, et al
    Comparison of predictors for terminal disease progression in SIV/SHIV-infected rhesus macaques.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96465.
    PubMed     Abstract available

  262. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96464.
    PubMed     Abstract available

  263. KAPETANOVIC S, Giganti MJ, Abzug MJ, Lindsey JC, et al
    Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96463.
    PubMed     Abstract available

  264. WANG Z, Manion MM, Laidlaw E, Rupert A, et al
    Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96458.
    PubMed     Abstract available

  265. MOUNZER K, Brunet L, Wyatt CM, Fusco JS, et al
    To dose-adjust or not to dose-adjust: 3TC dose in kidney impairment.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96461.
    PubMed     Abstract available

  266. TAPIA GR, Glynn TR, Miller C, Manuzak JA, et al
    Syndemics and pre-exposure prophylaxis are independently associated with rectal immune dysregulation in sexual minority men.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96460.
    PubMed     Abstract available

  267. CONNOLLY S, Carlson JM, Schaefer M, Bere A, et al
    HLA-associated preadaptation in HIV Vif is associated with higher set point viral load and faster CD4 decline in Zambian transmission pairs.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96459.
    PubMed     Abstract available

  268. MORTON T, Chege W, Swann E, Senn TE, et al
    Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioral science: NIH workshop directions.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96457.

  269. VAN DEN HOF M, Jellema PEJ, Haar AMT, Scherpbier HJ, et al
    Normal structural brain development in adolescents treated for perinatally acquired HIV: A longitudinal imaging study.
    AIDS. 2021 Mar 8. pii: 00002030-900000000-96462.
    PubMed     Abstract available

  270. A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India: Erratum.
    AIDS. 2021;35:527.

  271. LUO G, Su L, Hu X, Lin YF, et al
    The role of e-commerce platforms in optimizing the HIV care continuum.
    AIDS. 2021;35:521-522.

  272. VANCE DE, Brew BJ
    HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
    AIDS. 2021;35:511-513.

  273. RIOS A
    Kaposi sarcoma: a fresh look.
    AIDS. 2021;35:515-516.

  274. ALDREDGE A, Roth G, Vaidya A, Paula Duarte A, et al
    Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia.
    AIDS. 2021;35:524-526.

  275. CATTANEO D, Vinti P, Baldelli S, Fusi M, et al
    Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.
    AIDS. 2021;35:522-524.

    February 2021
  276. DE FRANCESCO D, Sabin CA, Winston A, Mallon PWG, et al
    Agreement between self-reported and objective measures of sleep in people with HIV and lifestyle-similar HIV-negative individuals.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96476.
    PubMed     Abstract available

  277. MCCLUSKEY SM, Kamelian K, Musinguzi N, Kigozi S, et al
    Pre-treatment integrase inhibitor resistance is uncommon in ART-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96475.
    PubMed     Abstract available

  278. GUARALDI G, Calza S, Milic J, Calcagno A, et al
    Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96474.
    PubMed     Abstract available

  279. LI Y, Etemad B, Dele-Oni R, Sharaf R, et al
    Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96478.
    PubMed     Abstract available

  280. JAN AK, Moore JV, Wang RJ, Mcging M, et al
    Markers of inflammation and immune activation are associated with lung function in a multicenter cohort of persons with HIV.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96477.
    PubMed     Abstract available

  281. FALADE-NWULIA O, Seaberg EC, Snider AE, Rinaldo CR, et al
    Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96487.
    PubMed     Abstract available

  282. HAYS AG, Schar M, Barditch-Crovo P, Bagchi S, et al
    A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96486.
    PubMed     Abstract available

  283. HOLT M, Broady TR, Mao L, Chan C, et al
    Increasing pre-exposure prophylaxis use and 'net prevention coverage' in behavioural surveillance of Australian gay and bisexual men, 2014-19.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96485.
    PubMed     Abstract available

  284. KIMMEL SD, Walley AY, Lodi S, Forman LS, et al
    Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96484.
    PubMed     Abstract available

  285. HATCHER AM, Brittain K, Phillips TK, Zerbe A, et al
    Longitudinal association between intimate partner violence and viral suppression during pregnancy and postpartum in South African women.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96483.
    PubMed     Abstract available

  286. NELSON M, Winston A, Hill A, Mngqibisa R, et al
    Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96482.
    PubMed     Abstract available

  287. MOODLEY Y, Tomita A, de Oliveira T, Tanser F, et al
    HIV viral load and pregnancy loss: Results from a population-based cohort study in rural KwaZulu-Natal, South Africa.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96481.
    PubMed     Abstract available

  288. SHIAU S, Brummel SS, Kennedy EM, Hermetz K, et al
    Longitudinal changes in epigenetic age in youth with perinatally-acquired HIV and youth who are perinatally HIV-exposed uninfected.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96480.
    PubMed     Abstract available

  289. EKENBERG C, Reekie J, Zucco AG, Murray DD, et al
    The association of HLA alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96479.
    PubMed     Abstract available

  290. YANG FN, Bronshteyn M, Flowers SA, Dawson M, et al
    Low CD4 nadir exacerbates the impacts of APOE epsilon4 on functional connectivity and memory in adults with HIV.
    AIDS. 2021 Feb 5. pii: 00002030-900000000-96491.
    PubMed     Abstract available

  291. LUPO J, Germi R, Lancar R, Algarte-Genin M, et al
    Prospective evaluation of blood Epstein Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas.
    AIDS. 2021 Feb 5. doi: 10.1097/QAD.0000000000002839.
    PubMed     Abstract available

  292. MELLOR MM, Bast AC, Jones NR, Roberts NW, et al
    Risk of adverse COVID-19 outcomes for people living with HIV: a rapid review and meta-analysis.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96494.
    PubMed     Abstract available

  293. ZOU W, Xing J, Wang F, Chen X, et al
    HIV-1LAI Nef blocks the development of hematopoietic stem/ progenitor cells into T lymphoid cells.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96493.
    PubMed     Abstract available

  294. ROTHAN C, Yero A, Shi T, Farnos O, et al
    ART-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96492.
    PubMed     Abstract available

  295. HAMZAH L, Post FA
    Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravir.
    AIDS. 2021;35:349-351.

  296. ROTHERAM-BORUS MJ, Wynn A, Stewart J, Almirol E, et al
    Outcomes of HIV-exposed but uninfected children in South Africa over 5 years.
    AIDS. 2021;35:347-349.

  297. JOSEPH DAVEY DL, de Villiers L, Evens E
    Importance of rigorous implementation science studies to scale-up evidence-based interventions to end the HIV epidemic in the United States.
    AIDS. 2021;35:335-336.

  298. MOYO F, Mazanderani AH, Murray T, Sherman GG, et al
    Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa.
    AIDS. 2021;35:307-316.
    PubMed     Abstract available

  299. SALVATORE PP, de Broucker G, Vojnov L, Moss WJ, et al
    Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
    AIDS. 2021;35:287-297.
    PubMed     Abstract available

  300. MCENTIRE CRS, Fong KT, Jia DT, Cooper ER, et al
    Central nervous system disease with JC virus infection in adults with congenital HIV.
    AIDS. 2021;35:235-244.
    PubMed     Abstract available

  301. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    PubMed     Abstract available

  302. CAZZANIGA A, Scrimieri R, Galli M, Maier J, et al
    Unveiling the basis of antiretroviral therapy-induced osteopenia: the effects of Dolutegravir, Darunavir and Atazanavir on osteogenesis.
    AIDS. 2021;35:213-218.
    PubMed     Abstract available

  303. WANG Y, Lin X, Wen Y
    Organizing pneumonia-presenting acute respiratory distress syndrome because of paradoxical tuberculosis-immune reconstitution disease?
    AIDS. 2021;35:351-354.

    January 2021
  304. WANG L, Moqueet N, Simkin A, Knight J, et al
    Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96503.
    PubMed     Abstract available

  305. MADEDDU G, De Vito A, Cozzi-Lepri A, Cingolani A, et al
    Time spent with viral load
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96502.
    PubMed     Abstract available

  306. OLIVEIRA NL, Kennedy EH, Tibshirani R, Levine A, et al
    Longitudinal 5-year prediction of cognitive impairment among men with HIV disease.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96501.
    PubMed     Abstract available

  307. MUCCINI C, Galli L, Poli A, Godino C, et al
    Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96500.
    PubMed     Abstract available

  308. GEBREBRHAN H, Kambaran C, Sivro A, Adhiambo W, et al
    Rectal microbiota diversity in Kenyan men who have sex with men (MSM) is inversely associated with frequency of receptive anal sex, independent of HIV status.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96499.
    PubMed     Abstract available

  309. CHAN P, Kerr SJ, Kroon E, Colby D, et al
    Cognitive trajectories after treatment in acute HIV infection.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96498.
    PubMed     Abstract available

  310. NYAKATO P, Schomaker M, Sipambo N, Technau KG, et al
    Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa.
    AIDS. 2021 Jan 21. pii: 00002030-900000000-96504.
    PubMed     Abstract available

  311. ARANTES I, Bello G, Darcissac E, Lacoste V, et al
    Using phylogenetic surveillance and epidemiological data to understand the HIV-1 transmission dynamics in French Guiana.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96506.
    PubMed     Abstract available

  312. JOHNSTON PI, Wright SW, Orr M, Pearce FA, et al
    Worldwide relative smoking prevalence among people living with and without HIV: a systematic review and meta-analysis.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96505.
    PubMed     Abstract available

    Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96508.
    PubMed     Abstract available

  314. KANG R, Li J, Chen H, Tang Z, et al
    Using longitudinal genetic-network study to understand HIV treatment-as-prevention: a population-based observational study.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96507.
    PubMed     Abstract available

  315. LIU FF, Hall V, Cronin KM, Nair AP, et al
    'Peeling back the onion layers': the challenge of HIV-associated multicentric Castleman's disease.
    AIDS. 2021;35:159-161.

  316. ASHOK A, Hoy J, Spelman D, McMahon J, et al
    Successful treatment of disseminated Mycobacterium simiae infection in a patient with advanced HIV.
    AIDS. 2021;35:157-158.

  317. TRAEGER MW, Patel P, Guy R, Hellard ME, et al
    Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions.
    AIDS. 2021;35:155-157.

  318. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2021;35:151-154.
    PubMed     Abstract available

  319. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    AIDS. 2021;35:53-62.
    PubMed     Abstract available

    December 2020
  320. LAM JO, Hou CE, Hojilla JC, Anderson AN, et al
    Comparison of dementia risk after age 50 between individuals with and without HIV infection.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  321. BRANDAO M, Bruzzone M, Franzoi MA, de Angelis C, et al
    Impact of HIV infection on baseline characteristics and survival of women with breast cancer: a systematic review and meta-analysis.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  322. RITTENHOUSE KJ, Mwape H, Nelson JA, Mwale J, et al
    Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  323. NTHOBATSANG K, Ncenga TL, Mwangi-Woto C, Wedu TJ, et al
    Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  324. BUDD A, Krentz HB, Rubin LH, Power C, et al
    Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  325. NGONGO NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, et al
    Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC.
    AIDS. 2020;Publish Ahead of Print.

  326. TORDOFF DM, Buskin S, Lechtenberg R, Golden MR, et al
    Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents of King County, Washington.
    AIDS. 2020 Dec 10. doi: 10.1097/QAD.0000000000002783.
    PubMed     Abstract available

  327. KIMURA CMS, Nahas CSR, Silva-Filho EV, Ribeiro VL, et al
    High-risk HPV test in anal smears: can it optimize the screening for anal cancer?
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002795.
    PubMed     Abstract available

  328. HICKEY MD, Imbert E, Glidden DV, Rosario JBD, et al
    Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002793.
    PubMed     Abstract available

  329. MOCROFT A
    The relationship between smoking, current CD4, viral load and cancer in persons living with HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002791.
    PubMed     Abstract available

  330. FALASCA K, Lanuti P, Ucciferri C, Pieragostino D, et al
    Circulating extracellular vesicles as new inflammation marker in hiv infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002794.
    PubMed     Abstract available

  331. HANDOKO R, Chan P, Jagodzinski L, Pinyakorn S, et al
    Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002786.
    PubMed     Abstract available

  332. MU W, Sharma M, Heymans R, Ritou E, et al
    ApoA-I mimetics attenuate macrophage activation in chronic treated HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002785.
    PubMed     Abstract available

  333. XIANG Y, Fujimoto K, Li F, Wang Q, et al
    Identifying influential neighbors in social networks and venue affiliations among young MSM: A data science approach to predict HIV infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002784.
    PubMed     Abstract available

  334. FIORENTINO M, Eubanks A, Coulaud PJ, Couderc C, et al
    Homonegativity, sexual violence and condom use with women in men who have sex with men and women in West Africa (CohMSM).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002782.
    PubMed     Abstract available

  335. ESTCOURT C, Yeung A, Nandwani R, Goldberg D, et al
    Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM.
    AIDS. 2020 Dec 7. doi: 10.1097/QAD.0000000000002790.
    PubMed     Abstract available

  336. BAILEY JV, Wayal S, Aicken CRH, Webster R, et al
    Interactive digital interventions for prevention of sexually transmitted HIV: systematic review and meta-analyses.
    AIDS. 2020 Dec 4. doi: 10.1097/QAD.0000000000002780.
    PubMed     Abstract available

  337. ONG JJ, Chow EPF, Read D, Taj U, et al
    Nudgeathons to control HIV: designing strategies using behavioural economics.
    AIDS. 2020;34:2337-2340.

  338. AVDOSHINA V, Mocchetti I
    HIV-associated neurodegenerative disorders: extracellular and intracellular mechanisms.
    AIDS. 2020;34:2334-2336.

  339. ZHAO T
    HIV-associated neurodegenerative disorders: role of endoplasmic reticulum in Gp120-mediated neurotoxicity.
    AIDS. 2020;34:2333-2334.

  340. VINIKOOR MJ, Hachaambwa L
    Advanced HIV disease during the 'Treat All' era in Botswana.
    AIDS. 2020;34:2321-2323.

  341. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    AIDS. 2020;34:2295-2304.
    PubMed     Abstract available

  342. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing.
    AIDS. 2020;34:2201-2210.
    PubMed     Abstract available

  343. ABRAHAMS N, Mhlongo S, Dunkle K, Chirwa E, et al
    Increase in HIV incidence in women exposed to rape: a comparative cohort study.
    AIDS. 2020 Dec 1. doi: 10.1097/QAD.0000000000002779.
    PubMed     Abstract available

  344. WOOD BR
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy.
    AIDS. 2020;34:2319-2320.

    November 2020
  345. MARTY L, Lemsalu L, Kivite-Urtane A, Costagliola D, et al
    Revealing HIV epidemic dynamics and contrasting responses in two WHO Eastern European countries: insights from modeling and data triangulation.
    AIDS. 2020 Nov 30. doi: 10.1097/QAD.0000000000002778.
    PubMed     Abstract available

  346. SEYEDALINAGHI S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, et al
    HIV in Iran: onset, responses and future directions.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002757.
    PubMed     Abstract available

  347. XIA Y, Milwid RM, Godin A, Boily MC, et al
    Accuracy of self-reported HIV testing history and awareness of HIV-positive status among people living with HIV in four Sub-Saharan African countries.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002759.
    PubMed     Abstract available

  348. SUNDERMANN EE, Fields A, Saloner R, Gouaux B, et al
    The utility of olfactory function in distinguishing early stage Alzheimer's disease from HIV-associated neurocognitive disorder.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002761.
    PubMed     Abstract available

  349. MCFALL AM, Lau B, Latkin C, Srikrishnan AK, et al
    Optimizing respondent driven sampling to find undiagnosed HIV-infected people who inject drugs.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002763.
    PubMed     Abstract available

  350. ROSEBUSH JC, Best BM, Chadwick EG, Butler K, et al
    Pharmacokinetics and safety of maraviroc in neonates.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002762.
    PubMed     Abstract available

  351. TREVILLYAN JM, Dart A, Paul E, Cavassini M, et al
    Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk; a randomised, controlled trial.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002764.
    PubMed     Abstract available

  352. DESMONDE S, Ciaranello AL, Malateste K, Musick B, et al
    Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus non-perinatally-acquired HIV.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002765.
    PubMed     Abstract available

  353. HUAMAN MA, Juchnowski SM, Zidar DA, Kityo CM, et al
    Monocyte activation in persons living with HIV and tuberculosis coinfection.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002766.
    PubMed     Abstract available

  354. BROOKS KM, Momper JD, Pinilla M, Stek AM, et al
    Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002767.
    PubMed     Abstract available

  355. COOLEY SA, Paul RH, Strain JF, Boerwinkle A, et al
    Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002768.
    PubMed     Abstract available

  356. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Maintenance of statin therapy among people living with HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002769.
    PubMed     Abstract available

  357. GROENE EA, Valeris-Chacin RJ, Stadelman AM, Safo SE, et al
    Maternal HIV and child anthropometric outcomes over time: An analysis of Zimbabwe demographic health surveys from 2005-2015.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002772.
    PubMed     Abstract available

  358. BAKER JV, Wolfson J, Collins G, Morse C, et al
    Losartan to reduce inflammation and fibrosis endpoints in HIV disease (LIFE-HIV): results from a randomized placebo-controlled trial.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002773.
    PubMed     Abstract available

  359. ZEZIULIN O, Mollan KR, Shook-Sa BE, Hanscom B, et al
    Depressive symptoms and use of HIV care and medication-assisted treatment among people living with HIV who inject drugs.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002774.
    PubMed     Abstract available

  360. TSHIKUNG ON, Smit M, Marinosci A, Buvelot H, et al
    Caring for people living with HIV during the global COVID-19 pandemic.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002775.

  361. GARCIA M, Morcilla V, Navarrete-Munoz MA, Fisher K, et al
    HIV-DNA Content in pTfh Cells is Associated with Residual Viremia in Elite Controllers.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002776.
    PubMed     Abstract available

  362. VELLOZA J, Kapogiannis B, Bekker LG, Celum C, et al
    Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth PrEP services?
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002777.
    PubMed     Abstract available

  363. ERLANDSON KM, Wu K, Lake JE, Samuels DC, et al
    Mitochondrial DNA haplogroups and weight gain following switch to INSTI-Based ART.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002771.
    PubMed     Abstract available

  364. HUGHES K, Chang J, Stadtler H, Wyatt C, et al
    HIV-1 infection of the kidney: mechanisms and implications.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002753.
    PubMed     Abstract available

  365. CHOW FC, Ma Y, Manion M, Rupert A, et al
    Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002755.
    PubMed     Abstract available

  366. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases Consensus panel: Erratum.
    AIDS. 2020;34:2161-2163.

  367. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients: Erratum.
    AIDS. 2020;34:2159.

  368. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020;34:2152-2155.

  369. SOUDEYNS H, Dumond J
    Unexpectedly low levels of transplacental transfer of second-generation integrase strand transfer inhibitors bictegravir and cabotegravir.
    AIDS. 2020;34:2137-2139.

  370. LEVY JA, Coutinho RA, Saag MS
    AIDS new editor announcement.
    AIDS. 2020;34:1995.

  371. FARR ZUEND C, Noel-Romas L, Hoger S, Mccorriser S, et al
    Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002751.
    PubMed     Abstract available

  372. BEDIMO RJ, Park LS, Shebl F, Sigel K, et al
    Statin exposure and risk of cancer in people with and without HIV infection.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002748.
    PubMed     Abstract available

  373. SEVERIN D, Faiza B, Nadia M, Aurelie DT, et al
    Kaposi sarcoma in people living with HIV: a comparative study of classic and HIV-viremic and aviremic AIDS Kaposi Sarcoma.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002744.
    PubMed     Abstract available

  374. ADAMS JW, Khan MR, Bessey SE, Friedman SR, et al
    Pre-exposure prophylaxis (PrEP) strategies for African American Women Affected by Mass Incarceration: A Modeling Study.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002749.
    PubMed     Abstract available

  375. REIN SM, Lampe FC, Johnson MA, Bhagani S, et al
    All-cause hospitalisation according to demographic group in people living with HIV in the current ART era: Recent findings from a cohort study in the UK.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002750.
    PubMed     Abstract available

  376. NICHOLS BE, Cele R, Jamieson L, Long LC, et al
    Community-based delivery of HIV treatment in Zambia: costs and outcomes.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002737.
    PubMed     Abstract available

  377. COLLINS LF, Colasanti JA, Nguyen ML, Moran CA, et al
    The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002746.

  378. PASVOL TJ, Teh J, Balfoussia D, Hall R, et al
    Outcomes of fertility investigations in a cohort of adults with perinatally acquired HIV-1 infection: a UK cross-sectional observational study.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002745.
    PubMed     Abstract available

  379. TAGO A, McKinnon LR, Wanjiru T, Muriuki F, et al
    Declines in HIV prevalence in female sex workers (FSWs) accessing an HIV treatment and prevention programme in Nairobi, Kenya over a 10-year period.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002747.
    PubMed     Abstract available

  380. Assessing the validity of and factors that influence accurate self-reporting of HIV status after testing: a population-based study: Erratum.
    AIDS. 2020;34:1993.

  381. GREEN M
    A letter to a young HIV doctor.
    AIDS. 2020;34:1991-1992.

  382. GABUZDA D, McArthur JC, Letendre SL
    Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system.
    AIDS. 2020;34:1975-1977.

  383. PYRA M, Rusie L, Castro M, Keglovitz Baker K, et al
    A taxonomy of pragmatic measures of HIV preexposure prophylaxis use.
    AIDS. 2020;34:1951-1957.
    PubMed     Abstract available

  384. MILIC J, Menozzi V, Schepis F, Malagoli A, et al
    Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    AIDS. 2020;34:1915-1921.
    PubMed     Abstract available

  385. LO B
    Toward respectful research with Indigenous people.
    AIDS. 2020;34:1979-1981.

  386. ROELOFSEN EE, Wildenbeest S, Mollema FP, Burger DM, et al
    Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomy.
    AIDS. 2020;34:1989-1991.

    October 2020
  387. SUGAWARA S, Manickam C, Reeves RK
    TRIGGERED: could refocused cell signaling be key to NK cell-based HIV immunotherapeutics?
    AIDS. 2020 Oct 27. doi: 10.1097/QAD.0000000000002743.
    PubMed     Abstract available

  388. SHERMAN BT, Hu X, Singh K, Haine L, et al
    Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002738.
    PubMed     Abstract available

  389. CHANDIWANA NC, Chersich M, Venter WF, Akpomiemie G, et al
    Unexpected interactions between dolutegravir and folate: randomised trial evidence from South Africa.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002741.
    PubMed     Abstract available

  390. CHLOE O, Elion R, Thompson M, Rockstroh JK, et al
    Changes in weight and body mass index with first-line doravirine-based therapy: a pooled analysis of three randomized controlled trials.
    AIDS. 2020 Oct 13. doi: 10.1097/QAD.0000000000002725.
    PubMed     Abstract available

  391. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002730.
    PubMed     Abstract available

  392. TEMU TM, Zifodya JS, Polyak SJ, Wagoner J, et al
    Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002729.
    PubMed     Abstract available

  393. BAJEMA KL, Nance RM, Delaney JAC, Eaton E, et al
    Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002679.
    PubMed     Abstract available

  394. WHITEMAN A, Baugher A, Sionean C
    Assessing self-reported discrimination among men who have sex with men.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002711.
    PubMed     Abstract available

  395. LU D, Sun H, Yu J, Kuang YQ, et al
    Chemsex drugs regulate HIV infection and replication in immune cells: A vicious circle.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002708.

  396. KOHLI M, Moore DJ, Moore RC
    Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002726.

  397. GILMORE JC, Serghides L, Bendayan R
    Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002707.
    PubMed     Abstract available

  398. DES JARLAIS DC, Duong Thi H, Khuat Thi Hai O, Feelemyer JP, et al
    Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002712.
    PubMed     Abstract available

  399. ROURKE SB, Bekele T, Rachlis A, Kovacs C, et al
    Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002709.
    PubMed     Abstract available

  400. AUDET CM, Ngobeni S, Mkansi M, Wafawanaka F, et al
    An unrecognized key population? traditional treatment practices associated with HIV risk among traditional healers in rural South Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002710.
    PubMed     Abstract available

  401. SHANGANI S, Bhaskar N, Richmond N, Operario D, et al
    A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002713.
    PubMed     Abstract available

  402. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of pre-exposure prophylaxis in the Netherlands - a mixed-methods analysis.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002714.
    PubMed     Abstract available

  403. SIBIUDE J, Le Chenadec J, Mandelbrot L, Dollfus C, et al
    Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002719.
    PubMed     Abstract available

  404. NJUGUNA IN, Wagner AD, Neary J, Omondi VO, et al
    Financial incentives to increase pediatric hiv testing: a randomized trial.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002720.
    PubMed     Abstract available

  405. CARLANDER C, Wagner P, Yilmaz A, Sparen P, et al
    Employment by HIV status, mode of HIV transmission and migrant status: a nation-wide population-based study with twenty years of follow-up.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002724.
    PubMed     Abstract available

  406. SHANAUBE K, Schaap A, Hoddinott G, Mubekapi-Musadaidzwa C, et al
    Impact of a community-wide combination HIV prevention intervention on knowledge of HIV status among adolescents.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002722.
    PubMed     Abstract available

  407. HSU R, Brunet L, Fusco JS, Mounzer K, et al
    Incident Type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002718.
    PubMed     Abstract available

  408. JONES CI, Rose SL, Shutt A, Cairo C, et al
    Maternal HIV status skews transcriptomic response in infant cord blood monocytes exposed to BCG.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002706.
    PubMed     Abstract available

  409. ZHANG J, Thakuri BKC, Zhao J, Nguyen LN, et al
    LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002700.
    PubMed     Abstract available

  410. HESSOL NA, Barrett BW, Margolick JB, Plankey M, et al
    Risk of smoking-related cancers among women and men living with and without hiv.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002717.
    PubMed     Abstract available

  411. WAGMAN JA, Wynn A, Matsuzaki M, Gnatienko N, et al
    Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002716.
    PubMed     Abstract available

  412. VONASEK B, Kay A, Devezin T, Bacha JM, et al
    Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002715.
    PubMed     Abstract available

  413. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a gag mutation that abrogates KIR binding and disinhibits NK cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002721.
    PubMed     Abstract available

  414. PILKINGTON V, Hughes SL, Pepperrell T, McCann K, et al
    Tenofovir alafenamide versus tenofovir disoproxil fumarate - an updated meta-analysis of 14,894 patients across 14 trials.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002699.
    PubMed     Abstract available

  415. MURAKOSHI H, Chikata T, Akahoshi T, Zou C, et al
    Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002704.
    PubMed     Abstract available

  416. SERRANO PA, Daubert E, Munoz A, Hosek SG, et al
    Effect of Truvada lawsuit advertising on PrEP attitudes and decisions among sexual and gender minority youth and young adults at risk for HIV.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002728.
    PubMed     Abstract available

  417. GRANT M
    Regulation of natural killer cells: analog peptide handshake goes digital.
    AIDS. 2020;34:1857-1858.

  418. EL-SADR WM
    What one pandemic can teach us in facing another.
    AIDS. 2020;34:1757-1759.

    September 2020
  419. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance Profile of Human Immunodeficiency Virus 1 (HIV-1) Quasispecies in Patients Under Treatment Failure Using Single Molecule, Real-Time (SMRT) Sequencing.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002697.
    PubMed     Abstract available

  420. LEVY JA
    The need to reassess our approaches at HIV cure and prevention.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002695.

  421. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002692.
    PubMed     Abstract available

  422. CHIAO E, Lensing SY, Wiley DJ, Deshmukh AA, et al
    Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002694.
    PubMed     Abstract available

  423. YOTSUMOTO M, Hachiya A, Ichiki A, Amano K, et al
    Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002688.

  424. BANDA FM, Powis KM, Sun S, Makhema J, et al
    Fetal biometry following in utero exposure to dolutegravir- or efavirenz-based antiretroviral therapy.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002674.

  425. SEELEY J, Blanc AK
    Reducing stigma and discrimination: new evidence and its implications.
    AIDS. 2020;34 Suppl 1:S1-S4.

    June 2020
  426. YADAVA SK, Vyas V, Jain H, Fazili T, et al
    Thrombotic thrombocytopenic purpura associated with AIDS: challenges in diagnosis and management.
    AIDS. 2020;34:1101-1102.

  427. ASHIGBIE PG, Laing RO, Wirtz VJ, Nkrumah N, et al
    Registration timelines of antiretroviral medicines in Ghana and Kenya.
    AIDS. 2020;34:1093-1095.
    PubMed     Abstract available

    March 2020
  428. ALAEI K, Zaidi H
    A centralized or decentralized approach when it comes to socially stigmatized health concerns in conservative social settings.
    AIDS. 2020;34:647-649.

  429. JAMES CW, Szabo S, Kahal D, Goldstein ND, et al
    The effect of multivitamins and polyvalent cations on virologic suppression with integrase strand transfer inhibitors.
    AIDS. 2020;34:487-489.

    In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene.
    AIDS. 2020;34:487.

    February 2020
  431. LIN KS, Win S, Nyein PP
    Drug-induced immune hemolytic anemia because of efavirenz: a case report.
    AIDS. 2020;34:326-328.

    December 2019
  432. CARR M, Richardson R, Tong W, Bloch M, et al
    Switch from tenofovir DF to raltegravir is not associated with weight gain over 96 weeks.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002473.
    PubMed     Abstract available

    September 2019
  433. LAPADULA G, Bernasconi DP, Bai F, Foca E, et al
    Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances: Results from a randomized controlled trial.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002377.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.